Citius Oncology Inc. (CTOR)
NASDAQ: CTOR
· Real-Time Price · USD
1.61
-0.09 (-5.29%)
At close: Aug 20, 2025, 3:59 PM
1.63
1.24%
After-hours: Aug 20, 2025, 07:45 PM EDT
Citius Oncology Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Apr 30, 2021 |
PE Ratio | -14.49 | -2.15 | -3.09 | -3.65 | -39.83 | 388.12 | -54.04 | 1.62K | n/a | n/a | n/a | -30.07K | -101.22K | -20.22K |
PEG Ratio | 0.46 | -0.12 | 0.04 | 0.00 | 0.82 | -10.04 | -0.09 | -21.83 | n/a | n/a | n/a | -127.11 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 9.61 | 1.87 | 1.99 | 2.16 | 16.49 | 16.58 | 14.48 | 14.70 | 14.85 | n/a | 15.12 | n/a | n/a | n/a |
P/FCF Ratio | n/a | n/a | n/a | 787.14K | -2.09K | n/a | -4.68K | -9.68K | n/a | n/a | -22.7K | n/a | n/a | n/a |
P/OCF Ratio | n/a | n/a | n/a | 787.14K | -2.09K | n/a | -4.68K | -9.69K | n/a | n/a | -22.7K | n/a | n/a | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.12 | 0.11 | 0.09 | 0.08 | 0.04 | 0.03 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Quick Ratio | 0.02 | 0.05 | 0.06 | 0.08 | 0.01 | 0.03 | 0.03 | 0.07 | 1.00 | n/a | 11.85 | n/a | n/a | n/a |
Current Ratio | 0.35 | 0.36 | 0.39 | 0.34 | 0.01 | 0.03 | 0.03 | 0.07 | 1.00 | n/a | 11.85 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -30.76 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.17 | -0.22 | -0.16 | -0.15 | -0.1 | 0.01 | -0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Assets | -0.06 | -0.08 | -0.07 | -0.08 | -0.1 | 0.01 | -0.07 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Invested Capital | -0.13 | -0.19 | -0.14 | -0.13 | -0.01 | -0.01 | n/a | -0.01 | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |